Clinical Trial Update: HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency

View source ↗

Summary

HEMOLEVEN Expanded Access Program for prevention of surgical and postpartum hemorrhage in people with severe inherited Factor XI deficiency is no longer availab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Factor Xi Deficiency
• Postpartum Hemorrhage

Drugs mentioned

• HEMOLEVEN (Factor XI concentrate)

Snippet

Sponsor: Laboratoire français de Fractionnement et de Biotechnologies | Conditions: Wound; Rupture, Surgery, Cesarean Section, Postpartum Hemorrhage | Status: NO_LONGER_AVAILABLE